Is Element Solutions (ESI) Outperforming Other Basic Materials Stocks This Year?

Element Solutions (ESI) is up 32.9% year to date, versus gains of about 5.8% for the Basic Materials sector and 11.9% for its specialty chemicals industry. Its Zacks consensus full-year earnings estimate rose 3.5% over the past three months, and the stock has a Zacks Rank of #2 (Buy). The article also notes FUCHS SE ADR is up 11.8% year to date, with its current-year consensus EPS estimate up 5.6%.

Analysis

The signal is a mismatch worth monitoring, not a standalone earnings thesis: ESI’s large share-price lead is accompanied by a much smaller upward revision to full-year EPS estimates. That can reflect multiple expansion or expectations beyond the current estimate cycle; without valuation, cash-flow, and guidance data, we cannot distinguish durable re-rating from a crowded momentum trade. The article’s point-in-time figures also lack a clear measurement date, limiting their use as a live catalyst.

Over days, momentum could persist, but the risk is reversal if estimate revisions stall. Over 1–3 months, the key test is whether reported results and management guidance validate the earnings trajectory. Over 6–18 months, any durable outperformance would need support from business-level growth and margins—not sector-ranking methodology. FUCHS SE (FPE3) offers a potential relative-value comparator, but the article provides no basis to conclude its fundamentals or valuation are superior. A relative position is premature without current valuation, estimate breadth, and comparable business exposure.

Key Decisions for Investors

• Do not chase ESI solely on the reported year-to-date outperformance. Verify the data date, current valuation, forward EPS revisions, and management guidance before adding exposure.
• Set an ESI watch alert: continued upward estimate revisions alongside resilient results would support the trend; flat or falling estimates combined with relative underperformance versus specialty chemicals would falsify it and argue against holding a momentum thesis.
• No immediate ESI/FPE3 pair trade: consider a conditional short-ESI/long-FPE3 relative position only if ESI estimate revisions turn down and its relative price trend breaks, after confirming comparable exposures and valuation. Define risk by the relative-trend invalidation rather than an unsupported price target.
• For the next earnings cycle, monitor organic growth, margins, and guidance versus consensus for ESI; these are the missing checks needed to determine whether the share-price advance is earnings-backed or primarily a re-rating.